BunyaVax
Lelystad
About BunyaVax
BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer. The unique ‘Plug and Play’ platforms are used to generate potent vaccines that can encode almost any antigen of interest. Applications are in the veterinary and human setting.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $83.3K
- Last round: Grant (Jun 2018)
- Website: bunyavax.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/bunyavax-2237786 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.